Popular Articles

Endocrine Society supports policies that prevent the illegal and non-medical uses of steroids
In light of yesterday"s Public Health Advisory from the Food and Drug Administration (FDA) warning consumers to immediately stop using all body-building products that claim to contain steroids or steroid-like substances, The Endocrine Society is re-issuing its Position Statement on Steroid Abuse initially launched in 2008.
drugs without prescription
No Evidence That Combined DTP-HBV-Hib Vaccine Works Better
There is no evidence that giving infants a combination vaccine for diphtheria (D), tetanus (T), pertussis (P), hepatitis B (HBV), and Haemophilus influenza type B (Hib) protects them as effectively as separate vaccines, according to the results of a new Cochrane review.
News of the day
Transplant Drug Stimulates Immune Memory
Rapamycin, a drug given to transplant recipients to suppress their immune systems, has a paradoxical effect on cells responsible for immune memory, scientists at the Emory Vaccine Center have discovered.
Endocrinology

AcroMetrix Announces The Release Of OptiQual(R) GBS Positive Control For Use With Diagnostic Assays That Detect Group B Streptococcus

AcroMetrix, a leading manufacturer of quality control standards and controls for clinical diagnostic and blood testing laboratories, announced the release of the first standardized quality control for molecular Group B Streptococcus (GBS) testing. The OptiQual GBS Positive Control is designed to help clinical laboratories comply with CLIA guidelines for qualitative molecular assays that detect Group B Streptococcus DNA, ensuring accuracy and precision throughout the testing procedure. Colonization of an expectant mother with Group B Streptococcus can pose an extreme threat to the newborn, potentially causing pneumonia, sepsis, or meningitis. In order to appropriately manage prevention of GBS transmission, obstetricians and labor and delivery nurses are beginning to utilize the more rapid and sensitive methods of PCR-based GBS detection. "As rapid, point-of-care molecular assays for Group B Streptococcus begin to replace the traditional culture-screening method, doctors and clinical laboratory technologists will want appropriate quality control materials to accurately monitor the performance of their assays," says Michael J. Eck, President and CEO of AcroMetrix. "Ultimately, the goal is for doctors to more efficiently administer antibiotic prophylaxis in order to prevent GBS transmission from a mother to her newborn. AcroMetrix is dedicated to helping doctors achieve this goal by providing quality control products such as the OptiQual GBS Positive Control." The OptiQual GBS Positive Control is unassayed and contains inactivated whole Group B Streptococcus bacteria, providing a safer method of monitoring the entire molecular testing procedure from extraction through amplification and detection. Convenient and ready to use, the OptiQual GBS Positive Control is stored at refrigerated temperatures. This product is for in vitro diagnostic use. OptiQual is a registered trademark of AcroMetrix. AcroMetrix


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):